Schrodinger, Inc.

SDGR · Healthcare

$20.84

Markedsværdi: 1.56B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Schrodinger, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Zacks3. sep. 2026, 14.32

Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook?

CNW Group3. sep. 2026, 12.55

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

Business Wire1. sep. 2026, 12.30

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Zacks18. aug. 2026, 07.43

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci

Zacks17. aug. 2026, 13.56

4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma